ABSTRACT
Spinocerebellar ataxia 7 (SCA7) is a neurodegenerative disease caused by expansion of a CAG repeat in the coding region of the SCA7 gene. The disease primarily affects the cerebellum and the retina, but also many other central nervous system (CNS) structures as the disease progresses. Ataxin-7, encoded by the SCA7 gene, is a protein of unknown function expressed in many tissues including the CNS. In normal brain, ataxin-7 is found in the cytoplasm and/or nucleus of neurons, but in SCA7 brain ataxin-7 accumulates in intranuclear inclusions. Ataxin-7 is expressed ubiquitously, but mutation leads to neuronal death in only certain areas of the brain. This selective pattern of degeneration might be explained by interaction with a partner that is specifically expressed in vulnerable cells. We used a two-hybrid approach to screen a human retina cDNA library for ataxin-7-binding proteins, and isolated R85, a splice variant of Cbl-associated protein (CAP). R85 and CAP are generated by alternative splicing of the gene SH3P12 which we localized on chromosome 10q23-q24. The interaction between ataxin-7 and the SH3P12 gene products (SH3P12GPs) was confirmed by pull-down and co-immunoprecipitation. SH3P12GPs are expressed in Purkinje cells in the cerebellum. Ataxin-7 colocalizes with full-length R85 (R85FL) in co-transfected Cos-7 cells and with one of the SH3P12GPs in neuronal intranuclear inclusions in brain from a SCA7 patient. We propose that this interaction is part of a physiological pathway related to the function or turnover of ataxin-7. Its role in the pathophysiological process of SCA7 disease is discussed.
Subject(s)
Alternative Splicing/genetics , Brain/metabolism , Cell Nucleus/metabolism , Cytoskeletal Proteins/metabolism , Microfilament Proteins/metabolism , Nerve Tissue Proteins/metabolism , Neurons/physiology , RNA, Messenger/metabolism , Amino Acid Sequence , Animals , Ataxin-7 , Blotting, Northern , Blotting, Western , Brain/cytology , COS Cells/metabolism , Cytoskeletal Proteins/genetics , Fluorescent Antibody Technique , Glutathione Transferase/metabolism , Haplorhini , Humans , Immunoenzyme Techniques , In Situ Hybridization, Fluorescence , Inclusion Bodies/metabolism , Mice , Molecular Sequence Data , Nerve Tissue Proteins/genetics , Precipitin Tests , Protein Isoforms , Sequence Homology, Amino Acid , Two-Hybrid System Techniques , Yeasts/metabolism , beta-Galactosidase/metabolismABSTRACT
Defects in myosin VIIA are responsible for deafness in the human and mouse. The role of this unconventional myosin in the sensory hair cells of the inner ear is not yet understood. Here we show that the C-terminal FERM domain of myosin VIIA binds to a novel transmembrane protein, vezatin, which we identified by a yeast two-hybrid screen. Vezatin is a ubiquitous protein of adherens cell-cell junctions, where it interacts with both myosin VIIA and the cadherin-catenins complex. Its recruitment to adherens junctions implicates the C-terminal region of alpha-catenin. Taken together, these data suggest that myosin VIIA, anchored by vezatin to the cadherin-catenins complex, creates a tension force between adherens junctions and the actin cytoskeleton that is expected to strengthen cell-cell adhesion. In the inner ear sensory hair cells vezatin is, in addition, concentrated at another membrane-membrane interaction site, namely at the fibrillar links interconnecting the bases of adjacent stereocilia. In myosin VIIA-defective mutants, inactivity of the vezatin-myosin VIIA complex at both sites could account for splaying out of the hair cell stereocilia.
Subject(s)
Cadherins/metabolism , Cytoskeletal Proteins/metabolism , Membrane Proteins/chemistry , Membrane Proteins/metabolism , Myosins/chemistry , Myosins/metabolism , Alternative Splicing , Amino Acid Sequence , Animals , Cadherins/chemistry , Cell Line , Cytoskeletal Proteins/chemistry , Deafness/genetics , Deafness/metabolism , Dyneins , Hair Cells, Auditory/metabolism , Humans , In Vitro Techniques , Intercellular Junctions/metabolism , Macromolecular Substances , Membrane Proteins/genetics , Mice , Molecular Sequence Data , Mutation , Myosin VIIa , Myosins/genetics , Protein Binding , Protein Structure, Tertiary , alpha CateninABSTRACT
To gain an insight into the cellular function of the unconventional myosin VIIA, we sought proteins interacting with its tail region, using the yeast two-hybrid system. Here we report on one of the five candidate interactors we identified, namely the type I alpha regulatory subunit (RI alpha) of protein kinase A. The interaction of RI alpha with myosin VIIA tail was demonstrated by coimmunoprecipitation from transfected HEK293 cells. Analysis of deleted constructs in the yeast two-hybrid system showed that the interaction of myosin VIIA with RI alpha involves the dimerization domain of RI alpha. In vitro binding assays identified the C-terminal "4.1, ezrin, radixin, moesin" (FERM)-like domain of myosin VIIA as the interacting domain. In humans and mice, mutations in the myosin VIIA gene underlie hereditary hearing loss, which may or may not be associated with visual deficiency. Immunohistofluorescence revealed that myosin VIIA and RI alpha are coexpressed in the outer hair cells of the cochlea and rod photoreceptor cells of the retina. Our results strongly suggest that myosin VIIA is a novel protein kinase A-anchoring protein that targets protein kinase A to definite subcellular sites of these sensory cells.
